Measurement of differentially methylated INS DNA species in human serum samples as a biomarker of islet β cell death

Sarah A. Tersey, Jennifer B. Nelson, Marisa M. Fisher, Raghu Mirmira

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The death of islet β cells is thought to underlie the pathogenesis of virtually all forms of diabetes and to precede the development of frank hyperglycemia, especially in type 1 diabetes. The development of sensitive and reliable biomarkers of β cell death may allow for early therapeutic intervention to prevent or delay the development of diabetes. Recently, several groups including our own have reported that cell-free, differentially methylated DNA encoding preproinsulin (INS) in the circulation is correlated to β cell death in pre-type 1 diabetes and new-onset type 1 diabetes. Here, we present a step-by-step protocol using digital PCR for the measurement of cell-free INS DNA that is differentially methylated at cytosine at position -69 bp (relative to the transcriptional start site). We demonstrate that the assay can distinguish between methylated and unmethylated cytosine at position -69 bp, is linear across several orders of magnitude, provides absolute quantitation of DNA copy numbers, and can be applied to samples of human serum from individuals with new-onset type 1 diabetes and disease-free controls. The protocol described here can be adapted to any DNA species for which detection of differentially methylated cytosines is desired, whether from circulation or from isolated cells and tissues, and can provide absolute quantitation of DNA fragments.

Original languageEnglish (US)
Article numbere54838
JournalJournal of Visualized Experiments
Volume2016
Issue number118
DOIs
StatePublished - Dec 21 2016

Fingerprint

Biomarkers
Cell death
Medical problems
Islets of Langerhans
DNA
Cell Death
Type 1 Diabetes Mellitus
Cytosine
Serum
Hyperglycemia
Assays
Polymerase Chain Reaction
Tissue

Keywords

  • Biomarker
  • Diabetes
  • Digital PCR
  • Epigenetics
  • Genetics
  • Insulin
  • Islet
  • Issue 118

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Measurement of differentially methylated INS DNA species in human serum samples as a biomarker of islet β cell death. / Tersey, Sarah A.; Nelson, Jennifer B.; Fisher, Marisa M.; Mirmira, Raghu.

In: Journal of Visualized Experiments, Vol. 2016, No. 118, e54838, 21.12.2016.

Research output: Contribution to journalArticle

@article{6c4216c01f844737b19158985008ec61,
title = "Measurement of differentially methylated INS DNA species in human serum samples as a biomarker of islet β cell death",
abstract = "The death of islet β cells is thought to underlie the pathogenesis of virtually all forms of diabetes and to precede the development of frank hyperglycemia, especially in type 1 diabetes. The development of sensitive and reliable biomarkers of β cell death may allow for early therapeutic intervention to prevent or delay the development of diabetes. Recently, several groups including our own have reported that cell-free, differentially methylated DNA encoding preproinsulin (INS) in the circulation is correlated to β cell death in pre-type 1 diabetes and new-onset type 1 diabetes. Here, we present a step-by-step protocol using digital PCR for the measurement of cell-free INS DNA that is differentially methylated at cytosine at position -69 bp (relative to the transcriptional start site). We demonstrate that the assay can distinguish between methylated and unmethylated cytosine at position -69 bp, is linear across several orders of magnitude, provides absolute quantitation of DNA copy numbers, and can be applied to samples of human serum from individuals with new-onset type 1 diabetes and disease-free controls. The protocol described here can be adapted to any DNA species for which detection of differentially methylated cytosines is desired, whether from circulation or from isolated cells and tissues, and can provide absolute quantitation of DNA fragments.",
keywords = "Biomarker, Diabetes, Digital PCR, Epigenetics, Genetics, Insulin, Islet, Issue 118",
author = "Tersey, {Sarah A.} and Nelson, {Jennifer B.} and Fisher, {Marisa M.} and Raghu Mirmira",
year = "2016",
month = "12",
day = "21",
doi = "10.3791/54838",
language = "English (US)",
volume = "2016",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "118",

}

TY - JOUR

T1 - Measurement of differentially methylated INS DNA species in human serum samples as a biomarker of islet β cell death

AU - Tersey, Sarah A.

AU - Nelson, Jennifer B.

AU - Fisher, Marisa M.

AU - Mirmira, Raghu

PY - 2016/12/21

Y1 - 2016/12/21

N2 - The death of islet β cells is thought to underlie the pathogenesis of virtually all forms of diabetes and to precede the development of frank hyperglycemia, especially in type 1 diabetes. The development of sensitive and reliable biomarkers of β cell death may allow for early therapeutic intervention to prevent or delay the development of diabetes. Recently, several groups including our own have reported that cell-free, differentially methylated DNA encoding preproinsulin (INS) in the circulation is correlated to β cell death in pre-type 1 diabetes and new-onset type 1 diabetes. Here, we present a step-by-step protocol using digital PCR for the measurement of cell-free INS DNA that is differentially methylated at cytosine at position -69 bp (relative to the transcriptional start site). We demonstrate that the assay can distinguish between methylated and unmethylated cytosine at position -69 bp, is linear across several orders of magnitude, provides absolute quantitation of DNA copy numbers, and can be applied to samples of human serum from individuals with new-onset type 1 diabetes and disease-free controls. The protocol described here can be adapted to any DNA species for which detection of differentially methylated cytosines is desired, whether from circulation or from isolated cells and tissues, and can provide absolute quantitation of DNA fragments.

AB - The death of islet β cells is thought to underlie the pathogenesis of virtually all forms of diabetes and to precede the development of frank hyperglycemia, especially in type 1 diabetes. The development of sensitive and reliable biomarkers of β cell death may allow for early therapeutic intervention to prevent or delay the development of diabetes. Recently, several groups including our own have reported that cell-free, differentially methylated DNA encoding preproinsulin (INS) in the circulation is correlated to β cell death in pre-type 1 diabetes and new-onset type 1 diabetes. Here, we present a step-by-step protocol using digital PCR for the measurement of cell-free INS DNA that is differentially methylated at cytosine at position -69 bp (relative to the transcriptional start site). We demonstrate that the assay can distinguish between methylated and unmethylated cytosine at position -69 bp, is linear across several orders of magnitude, provides absolute quantitation of DNA copy numbers, and can be applied to samples of human serum from individuals with new-onset type 1 diabetes and disease-free controls. The protocol described here can be adapted to any DNA species for which detection of differentially methylated cytosines is desired, whether from circulation or from isolated cells and tissues, and can provide absolute quantitation of DNA fragments.

KW - Biomarker

KW - Diabetes

KW - Digital PCR

KW - Epigenetics

KW - Genetics

KW - Insulin

KW - Islet

KW - Issue 118

UR - http://www.scopus.com/inward/record.url?scp=85008721519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008721519&partnerID=8YFLogxK

U2 - 10.3791/54838

DO - 10.3791/54838

M3 - Article

C2 - 28060259

AN - SCOPUS:85008721519

VL - 2016

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 118

M1 - e54838

ER -